Actively Recruiting
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
Led by Astellas Pharma Inc · Updated on 2026-05-04
3000
Participants Needed
47
Research Sites
351 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to investigate the safety and effectiveness in routine clinical practice and actual clinical setting for all patients with rheumatoid arthritis (RA) treated with peficitinib.
CONDITIONS
Official Title
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients with rheumatoid arthritis (RA) treated with peficitinib for the first time.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 47 locations
1
Site JP00023
Aichi, Japan
Actively Recruiting
2
Site JP00005
Akita, Japan
Actively Recruiting
3
Site JP00002
Aomori, Japan
Actively Recruiting
4
Site JP00012
Chiba, Japan
Actively Recruiting
5
Site JP00038
Ehime, Japan
Actively Recruiting
6
Site JP00018
Fukui, Japan
Actively Recruiting
7
Site JP00040
Fukuoka, Japan
Actively Recruiting
8
Site JP00007
Fukushima, Japan
Actively Recruiting
9
Site JP00021
Gifu, Japan
Actively Recruiting
10
Site JP00010
Gunma, Japan
Actively Recruiting
11
Site JP00034
Hiroshima, Japan
Actively Recruiting
12
Site JP00001
Hokkaido, Japan
Actively Recruiting
13
Site JP00028
Hyōgo, Japan
Actively Recruiting
14
Site JP00008
Ibaraki, Japan
Actively Recruiting
15
Site JP00017
Ishikawa, Japan
Actively Recruiting
16
Site JP00037
Kagawa, Japan
Actively Recruiting
17
Site JP00046
Kagoshima, Japan
Actively Recruiting
18
Site JP00014
Kanagawa, Japan
Actively Recruiting
19
Site JP00039
Kochi, Japan
Actively Recruiting
20
Site JP00043
Kumamoto, Japan
Actively Recruiting
21
Site JP00026
Kyoto, Japan
Actively Recruiting
22
Site JP00024
Mie, Japan
Actively Recruiting
23
Site JP00004
Miyagi, Japan
Actively Recruiting
24
Site JP00045
Miyazaki, Japan
Actively Recruiting
25
Site JP00020
Nagano, Japan
Actively Recruiting
26
Site JP00042
Nagasaki, Japan
Actively Recruiting
27
Site JP00029
Nara, Japan
Actively Recruiting
28
Site JP00015
Niigata, Japan
Actively Recruiting
29
Site JP00003
Numakunai, Japan
Actively Recruiting
30
Site JP00033
Okayama, Japan
Actively Recruiting
31
Site JP00047
Okinawa, Japan
Actively Recruiting
32
Site JP00027
Osaka, Japan
Actively Recruiting
33
Site JP00044
Ōita, Japan
Actively Recruiting
34
Site JP00041
Saga, Japan
Actively Recruiting
35
Site JP00011
Saitama, Japan
Actively Recruiting
36
Site JP00025
Shiga, Japan
Actively Recruiting
37
Site JP00032
Shimane, Japan
Actively Recruiting
38
Site JP00022
Shizuoka, Japan
Actively Recruiting
39
Site JP00009
Tochigi, Japan
Actively Recruiting
40
Site JP00036
Tokushima, Japan
Actively Recruiting
41
Site JP00013
Tokyo, Japan
Actively Recruiting
42
Site JP00031
Tottori, Japan
Actively Recruiting
43
Site JP00016
Toyama, Japan
Actively Recruiting
44
Site JP00030
Wakayama, Japan
Actively Recruiting
45
Site JP00006
Yamagata, Japan
Actively Recruiting
46
Site JP00035
Yamaguchi, Japan
Actively Recruiting
47
Site JP00019
Yamanashi, Japan
Actively Recruiting
Research Team
A
Astellas Pharma Inc.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here